Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

NCT00987493

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • St. Claraspital AG Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View all 16 locations
View Trial Details
Completed

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

NCT00227695

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Clinical Center - Institute of Hematology São Paulo, Brazil
  • Istituto Europeo di Oncologia IEO Milan, Italy
  • Clinical Center Skopje Skopje, North Macedonia
  • Clinical Center of Serbia Belgrade, Serbia
View all 26 locations
View Trial Details
Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00392691

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

NCT00544219

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • European Institute of Oncology Milan, Italy
  • Hirslanden Klinik Aarau Aarau, Switzerland
  • Kantonspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
View all 19 locations
View Trial Details
Completed

Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma

NCT02243436

Conditions
Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +7 more
Locations
  • Hospital Son Espases Palma, Balearic Islands, Spain
  • Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Central de Asturias Oviedo, Principality of Asturias, Spain
View all 14 locations
View Trial Details
Completed

Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma

NCT01980654

Conditions
B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University, Stanford Care Center Stanford, California, United States
View Trial Details

Related conditions